We are thrilled to announce that the Schubot Center has been awarded a seventh year of funding for its Avian Bornavirus ABV research from the Pat Palmer Foundation thanks to the leadership of Dr. Don Brightsmith from the Vet pathobiology Department and Dr. Sarah Hamer, Schubot Center director.
Over the past year, our team led by Dr. Caitlin Mencio, has made great advances. The testing of the environmental survival and disinfection of ABV is close to its conclusion and a draft manuscript is being prepared for publication. Additionally, the much-needed update information about ABV for the general public is in the final edits stages of preparation and it is almost ready for publication on our web page.
The ABV vaccine development is also going well. Over the next 12 months, the plan is to finish the study of a natural inoculation model and the preparation of new vaccine candidates. The team is also working on a quicker and more effective way to diagnose ABV with an immunoassay test that detects antibodies to ABV in 30 min, led by Dr. Jeff Musser.
We would like to thank the Pat Palmer Foundation for its continuing support to the Schubot Center research and for its commitment to helping fight the diseases associated with ABV.